The Peter Doherty Institute for Infection and Immunity is conducting a study of an experimental influenza (flu) vaccine using new mRNA technology and is seeking healthy adults 65 years and older.
The safety and ability of the new vaccine to promote a protective immune response is being compared to existing licensed flu vaccines.
We are looking for participants who are:
- Aged 65 years and older
- In good health
The study includes receiving one vaccine, as well as blood samples and follow-up for approximately 12 months.
You will be reimbursed for your travel and time on the study.
For more information and to volunteer, please contact:
• Email virgo-studies@unimelb.edu.au
• Phone 8344-9325
